Date published: 2026-1-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR4K14 Activators

Activators of the olfactory receptor OR4K14 exert their influence through various biochemical mechanisms that modulate the intracellular concentrations of cyclic nucleotides such as cAMP and cGMP. The activation process often involves the direct stimulation of adenylyl cyclase, an enzyme that catalyzes the conversion of ATP to cAMP, a secondary messenger intimately involved in the signaling processes of G protein-coupled receptors like OR4K14. The elevation of intracellular cAMP levels by certain activators reinforces the signaling cascade that ultimately potentiates the functional activity of OR4K14. Additionally, the inhibition of phosphodiesterases (PDEs), enzymes responsible for the breakdown of cAMP and cGMP, is another approach through which activators indirectly sustain enhanced receptor signaling. By preventing the degradation of these cyclic nucleotides, activators ensure a prolonged and amplified response of OR4K14 to its ligands.

Certain activators utilize a more targeted approach by specifically inhibiting types of PDEs, thereby increasing cAMP concentrations in a more controlled manner, leading to selective activation of OR4K14. Other activators may influence G protein-coupled receptor signaling through modulation of metal ion concentration, such as zinc, which is known to affect the function of a wide array of receptors. By manipulating the signaling environment in which OR4K14 operates, these activators indirectly foster an increase in the receptor's activity.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

Non-selective phosphodiesterase inhibitor, which prevents cAMP degradation, potentiating OR4K14.

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$28.00
$38.00
5
(0)

Beta-adrenergic agonist that elevates intracellular cAMP, thereby could activate OR4K14.

Cilostamide (OPC 3689)

68550-75-4sc-201180
sc-201180A
5 mg
25 mg
$92.00
$357.00
16
(1)

Inhibits PDE3, increasing cAMP concentration, which might lead to the activation of OR4K14.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$77.00
$216.00
18
(1)

PDE4 inhibitor, enhances cAMP levels, indirectly promoting OR4K14 signaling.

Zinc

7440-66-6sc-213177
100 g
$48.00
(0)

Can modulate G protein-coupled receptor signaling, potentially enhancing OR4K14 function.

Theophylline

58-55-9sc-202835
sc-202835A
sc-202835B
5 g
25 g
100 g
$20.00
$32.00
$85.00
6
(0)

Non-selective PDE inhibitor, increases cAMP levels, potentially enhancing OR4K14 activity.

Milrinone

78415-72-2sc-201193
sc-201193A
10 mg
50 mg
$165.00
$697.00
7
(0)

PDE3 inhibitor, increases cAMP levels, which might lead to the activation of OR4K14.

Papaverine

58-74-2sc-279951
sc-279951A
sc-279951B
10 mg
50 mg
100 mg
$153.00
$265.00
$459.00
(0)

Non-selective PDE inhibitor, increases cAMP, which could indirectly activate OR4K14.

Vinpocetine

42971-09-5sc-201204
sc-201204A
sc-201204B
20 mg
100 mg
15 g
$55.00
$214.00
$2400.00
4
(1)

PDE1 inhibitor, increases cAMP and cGMP levels, potentially activating OR4K14.

Zaprinast (M&B 22948)

37762-06-4sc-201206
sc-201206A
25 mg
100 mg
$105.00
$250.00
8
(2)

PDE5 inhibitor, leading to increased cAMP and cGMP, which may enhance OR4K14 activity.